協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2014/07/07 | 1,402 | 1,404 | 1,386 | 1,389 | -12 | -0.9% | 468,000 |
2014/07/04 | 1,403 | 1,407 | 1,396 | 1,401 | +9 | +0.6% | 457,000 |
2014/07/03 | 1,401 | 1,403 | 1,389 | 1,392 | -10 | -0.7% | 579,000 |
2014/07/02 | 1,400 | 1,409 | 1,392 | 1,402 | +9 | +0.6% | 713,000 |
2014/07/01 | 1,367 | 1,405 | 1,363 | 1,393 | +22 | +1.6% | 1,160,000 |
2014/06/30 | 1,363 | 1,373 | 1,342 | 1,371 | +9 | +0.7% | 1,232,000 |
2014/06/27 | 1,397 | 1,397 | 1,357 | 1,362 | -31 | -2.2% | 1,095,000 |
2014/06/26 | 1,410 | 1,412 | 1,389 | 1,393 | -6 | -0.4% | 1,098,000 |
2014/06/25 | 1,400 | 1,404 | 1,393 | 1,399 | +2 | +0.1% | 847,000 |
2014/06/24 | 1,378 | 1,401 | 1,368 | 1,397 | +20 | +1.5% | 795,000 |
2014/06/23 | 1,379 | 1,384 | 1,369 | 1,377 | -4 | -0.3% | 791,000 |
2014/06/20 | 1,359 | 1,384 | 1,359 | 1,381 | +23 | +1.7% | 1,606,000 |
2014/06/19 | 1,338 | 1,359 | 1,338 | 1,358 | +10 | +0.7% | 1,235,000 |
2014/06/18 | 1,337 | 1,350 | 1,327 | 1,348 | +7 | +0.5% | 898,000 |
2014/06/17 | 1,314 | 1,349 | 1,314 | 1,341 | +27 | +2.1% | 1,277,000 |
2014/06/16 | 1,309 | 1,320 | 1,305 | 1,314 | -4 | -0.3% | 895,000 |
2014/06/13 | 1,291 | 1,320 | 1,284 | 1,318 | +27 | +2.1% | 2,564,000 |
2014/06/12 | 1,301 | 1,301 | 1,280 | 1,291 | -15 | -1.1% | 1,113,000 |
2014/06/11 | 1,305 | 1,312 | 1,300 | 1,306 | +4 | +0.3% | 779,000 |
2014/06/10 | 1,305 | 1,313 | 1,298 | 1,302 | -4 | -0.3% | 1,088,000 |
2014/06/09 | 1,305 | 1,311 | 1,285 | 1,306 | +10 | +0.8% | 1,581,000 |
2014/06/06 | 1,281 | 1,308 | 1,277 | 1,296 | +35 | +2.8% | 2,579,000 |
2014/06/05 | 1,266 | 1,266 | 1,253 | 1,261 | -7 | -0.6% | 965,000 |
2014/06/04 | 1,265 | 1,268 | 1,255 | 1,268 | -3 | -0.2% | 938,000 |
2014/06/03 | 1,270 | 1,273 | 1,255 | 1,271 | +8 | +0.6% | 992,000 |
2014/06/02 | 1,247 | 1,264 | 1,236 | 1,263 | +30 | +2.4% | 1,281,000 |
2014/05/30 | 1,246 | 1,246 | 1,229 | 1,233 | -13 | -1% | 1,418,000 |
2014/05/29 | 1,252 | 1,255 | 1,239 | 1,246 | -6 | -0.5% | 585,000 |
2014/05/28 | 1,254 | 1,264 | 1,251 | 1,252 | +2 | +0.2% | 836,000 |
2014/05/27 | 1,247 | 1,257 | 1,244 | 1,250 | -4 | -0.3% | 849,000 |
2014/05/26 | 1,253 | 1,254 | 1,236 | 1,254 | +4 | +0.3% | 642,000 |
2014/05/23 | 1,242 | 1,253 | 1,241 | 1,250 | +17 | +1.4% | 769,000 |
2014/05/22 | 1,215 | 1,236 | 1,209 | 1,233 | +28 | +2.3% | 1,091,000 |
2014/05/21 | 1,189 | 1,210 | 1,189 | 1,205 | -1 | -0.1% | 685,000 |
2014/05/20 | 1,198 | 1,213 | 1,194 | 1,206 | +8 | +0.7% | 729,000 |
2014/05/19 | 1,183 | 1,205 | 1,183 | 1,198 | +17 | +1.4% | 835,000 |
2014/05/16 | 1,176 | 1,190 | 1,168 | 1,181 | -18 | -1.5% | 1,070,000 |
2014/05/15 | 1,200 | 1,202 | 1,181 | 1,199 | -11 | -0.9% | 755,000 |
2014/05/14 | 1,209 | 1,210 | 1,198 | 1,210 | +5 | +0.4% | 597,000 |
2014/05/13 | 1,210 | 1,217 | 1,200 | 1,205 | +11 | +0.9% | 1,181,000 |
2014/05/12 | 1,184 | 1,197 | 1,183 | 1,194 | +6 | +0.5% | 839,000 |
2014/05/09 | 1,183 | 1,192 | 1,178 | 1,188 | +4 | +0.3% | 1,115,000 |
2014/05/08 | 1,169 | 1,188 | 1,162 | 1,184 | +30 | +2.6% | 984,000 |
2014/05/07 | 1,151 | 1,165 | 1,148 | 1,154 | -25 | -2.1% | 1,273,000 |
2014/05/02 | 1,172 | 1,188 | 1,171 | 1,179 | +7 | +0.6% | 737,000 |
2014/05/01 | 1,152 | 1,174 | 1,152 | 1,172 | +8 | +0.7% | 851,000 |
2014/04/30 | 1,178 | 1,179 | 1,161 | 1,164 | -1 | -0.1% | 1,159,000 |
2014/04/28 | 1,168 | 1,169 | 1,152 | 1,165 | -7 | -0.6% | 897,000 |
2014/04/25 | 1,169 | 1,186 | 1,163 | 1,172 | +17 | +1.5% | 1,156,000 |
2014/04/24 | 1,160 | 1,162 | 1,150 | 1,155 | +1 | +0.1% | 658,000 |
2651~
2700
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 217,400円 | -3.5% | -11.3% | 2.76% | 19.97倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 135,300円 | +0.9% | +380.2% | 5.76% | 18.63倍 | 1.60倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 220,700円 | +20.9% | +10.6% | 2.99% | 10.43倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 388,100円 | +1.7% | -2.9% | 4.12% | 25.46倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 150,100円 | +0.6% | +43.3% | 5.33% | 10.52倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム